Biocloud order from $7 billion dollar companyKontrol Technologies Receives BioCloud Order from Global Technology Company Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol” or the “Company”), a leader in smart building technology, is shipping BioCloud units to a global technology company (the “Customer”), which operates in the field of technology testing and validation with approximate annual revenues of $7 billion. Following the completion of an NDA and technology review in Q3 2021, BioCloud has been selected by the Customer for various applications.
“This is another opportunity which demonstrates our ability to attract global organizations to the BioCloud technology platform,” said Paul Ghezzi. “In a short period of time, we have attracted multiple organizations that operate with a global footprint and represent scaling potential for the BioCloud technology across a variety of applications.”
Application Collaboration
Kontrol will work closely with its new Customer to determine which applications are best suited for deployment and will provide further updates on the new Customer in the near future. For industry competitive purposes the Customer name will not be disclosed.